DEVELOPMENT OF BIO 301: AN ENCAPSULATED NANOGENISTEIN THERAPY

$3,811,222FY2017Department of the ArmyDOD

Humanetics Corporation, Edina MN

Investigators

View source on USAspending →

DEVELOPMENT OF BIO 301: AN ENCAPSULATED NANOGENISTEIN THERAPY · GrantIndex